De Palma Cataldo, Delvecchio Antonella, Ferraro Valentina, Stasi Matteo, Casella Annachiara, Filippo Rosalinda, Caringi Silvio, Calbi Roberto, Inchingolo Riccardo, Longo Francesca Romana, Troia Michele, Memeo Riccardo, Tedeschi Michele
IRCCS Humanitas Research Hospital, Pancreatic Surgery, Rozzano, Milan, Italy.
Unit of Hepatobiliary and Pancreatic Surgery, Regional General Hospital "F. Miulli", Acquaviva delle Fonti, Bari, Italy.
Ann Surg Oncol. 2025 Sep 12. doi: 10.1245/s10434-025-18310-9.
Insulinoma is a rare, functioning pancreatic neuroendocrine tumor (PanNET) that typically presents with clinical manifestations associated with fasting hypoglycemia in accordance with Whipple's triad. Although most insulinomas have benign biological behavior, the severity of hypoglycemic symptoms necessitates prompt diagnosis and management. Surgical resection remains the treatment of choice, and parenchyma-sparing techniques, such as enucleation, are preferred when the tumor is solitary. However, when the tumor is located in anatomically challenging regions, the surgical approach can present significant difficulties, limiting the use of parenchyma-sparing surgery. We report the case of a 54-year-old female with an insulinoma localized to the uncinate process of the pancreas in a critical position due to its close proximity to the mesenteric vessels. The tumor was successfully managed with robotic enucleation using the da Vinci XI platform. Intraoperative imaging with ultrasound, complemented by indocyanine green (ICG) fluorescence imaging, provided real-time visualization of the hypervascular lesion and its relationship to nearby vascular structures, allowing for precise demarcation and safe resection. This case illustrates the advantages of combining advanced intraoperative imaging techniques with robotic surgery to achieve a parenchyma-sparing resection with minimal morbidity. The discussion highlights current literature and emerging evidence on the use of ICG and near-infrared (NIR) fluorescence in pancreatic surgery, underscoring its potential to improve outcomes in the management of pancreatic neuroendocrine tumors.
胰岛素瘤是一种罕见的、具有功能的胰腺神经内分泌肿瘤(PanNET),通常根据惠普尔三联征出现与空腹低血糖相关的临床表现。尽管大多数胰岛素瘤具有良性生物学行为,但低血糖症状的严重性需要及时诊断和处理。手术切除仍然是首选治疗方法,当肿瘤为孤立性时,首选保留实质的技术,如摘除术。然而,当肿瘤位于解剖结构复杂的区域时,手术入路可能会面临重大困难,限制了保留实质手术的应用。我们报告了一例54岁女性患者,其胰岛素瘤位于胰腺钩突部,位置关键,因为它紧邻肠系膜血管。使用达芬奇XI平台通过机器人摘除术成功处理了该肿瘤。术中超声成像辅以吲哚菁绿(ICG)荧光成像,实时显示了高血运病变及其与附近血管结构的关系,从而实现了精确的界限划分和安全切除。该病例说明了将先进的术中成像技术与机器人手术相结合以实现保留实质切除且并发症最少的优势。讨论突出了当前关于ICG和近红外(NIR)荧光在胰腺手术中应用的文献和新证据,强调了其改善胰腺神经内分泌肿瘤治疗效果的潜力。